Occudo Quantitative Strategies LP Makes New $485,000 Investment in Avanos Medical, Inc. (NYSE:AVNS)

Occudo Quantitative Strategies LP bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 30,446 shares of the company's stock, valued at approximately $485,000. Occudo Quantitative Strategies LP owned approximately 0.07% of Avanos Medical as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AVNS. Barclays PLC raised its stake in shares of Avanos Medical by 446.2% in the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after buying an additional 78,583 shares in the last quarter. JPMorgan Chase & Co. raised its position in Avanos Medical by 6.9% in the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock worth $1,672,000 after purchasing an additional 4,472 shares in the last quarter. Tributary Capital Management LLC lifted its stake in Avanos Medical by 38.1% during the fourth quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock worth $14,217,000 after purchasing an additional 246,379 shares during the period. Empowered Funds LLC boosted its holdings in Avanos Medical by 141.3% during the fourth quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock valued at $2,449,000 after purchasing an additional 90,091 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its holdings in Avanos Medical by 4.0% during the fourth quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock valued at $1,197,000 after purchasing an additional 2,921 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Price Performance

AVNS traded down $0.32 during midday trading on Wednesday, hitting $12.78. The company had a trading volume of 78,622 shares, compared to its average volume of 356,399. Avanos Medical, Inc. has a twelve month low of $11.84 and a twelve month high of $25.36. The firm's 50-day simple moving average is $13.13 and its 200-day simple moving average is $15.64. The company has a market capitalization of $591.00 million, a PE ratio of 37.57 and a beta of 1.13. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The business had revenue of $167.50 million during the quarter, compared to analyst estimates of $161.75 million. During the same quarter last year, the business posted $0.22 earnings per share. Avanos Medical's revenue for the quarter was up .8% compared to the same quarter last year. Equities research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Insider Activity

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. The trade was a 7.86% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.64% of the stock is currently owned by insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.